Committee advances Promoting Immunization Act after contentious hearing over liability and access

Sponsors Representative Brown and Representative Frey described SB032 as an effort to modernize Colorado’s immunization law to preserve access, clarify provider authority (notably pharmacists), and create a stable, state‑level process for vaccine recommendations if federal guidance becomes inconsistent. They said the bill does not create mandates or change exemptions.

Supporters—physicians, pharmacists, hospital associations, public‑health groups, and insurers—said recent federal instability prompted pharmacies to stop vaccinating in some situations and that the state needed a predictable framework. Pharmacists said the bill “crystallizes” authorities already in rule and would protect convenient access (pharmacies administered roughly 1.7 million vaccines in 2025, a witness said).

Opponents focused on the bill’s liability provisions, arguing expanded shields for providers, facilities or manufacturers could leave injured families with fewer civil remedies and expose the state to lawsuits if federal compensation programs are unavailable for vaccines not on a federal schedule. Several witnesses (parents and advocates) urged removing or narrowing liability protections and questioned the fiscal and accountability consequences for the state.

Committee action: Sponsors offered technical amendments (L015 and L016) to align statutory language with CDPHE practice, extend certain rule deadlines, clarify the Board of Health’s role, and allow funding through the annual budget process. Committee adopted the amendments and voted 8‑5 to send the bill, as amended, to the Committee of the Whole.

What’s next: SB032 moves to the Committee of the Whole. The hearing surfaced unsettled questions about liability language and whether the state should mirror federal protections for manufacturers and providers; sponsors and some legal observers said the core protections maintain accountability for negligence and fraud. Opponents warned of fiscal exposure if federal compensation programs no longer apply.